Serum biomarkers in interstitial lung diseases
<p>Abstract</p> <p>The use of biomarkers in medicine lies in their ability to detect disease and support diagnostic and therapeutic decisions. New research and novel understanding of the molecular basis of the disease reveals an abundance of exciting new biomarkers who present a pr...
Main Authors: | Anevlavis Stavros, Kouliatsis George, Tzouvelekis Argyris, Bouros Demosthenes |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-07-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://respiratory-research.com/content/6/1/78 |
Similar Items
-
Serum biomarkers in Acute Respiratory Distress Syndrome an ailing prognosticator
by: Pneumatikos Ioannis, et al.
Published: (2005-06-01) -
Clinical characteristics and outcome of lung cancer in patients with fibrosing interstitial lung disease
by: Soo Jin Han, et al.
Published: (2024-03-01) -
Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis
by: Shigemura Masahiko, et al.
Published: (2012-07-01) -
Interstitial lung disease: a review of classification, etiology, epidemiology, clinical diagnosis, pharmacological and non-pharmacological treatment
by: Malik A. Althobiani, et al.
Published: (2024-04-01) -
Plasma surfactant protein-D as a potential biomarker in idiopathic pulmonary fibrosis
by: Mohamed A. El Nady, et al.
Published: (2019-05-01)